TAK-041

CAS No. 1929519-13-0

TAK-041( NBI-1065846 )

Catalog No. M28601 CAS No. 1929519-13-0

TAK-041 is a potent and selective GPR139 agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 154 In Stock
5MG 140 In Stock
10MG 225 In Stock
25MG 452 In Stock
50MG 709 In Stock
100MG 1107 In Stock
200MG 1469 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TAK-041
  • Note
    Research use only, not for human use.
  • Brief Description
    TAK-041 is a potent and selective GPR139 agonist.
  • Description
    TAK-041 is a potent and selective GPR139 agonist.
  • In Vitro
    ——
  • In Vivo
    Animal Model:BALB/c mice Dosage:0.03, 0.3, and 3 mg/kg Administration:P.o.Result:Dose-dependently improved the social behavior of BALB/c mice.
  • Synonyms
    NBI-1065846
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    PDE5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1929519-13-0
  • Formula Weight
    392.33
  • Molecular Formula
    C18H15F3N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (254.89 mM)
  • SMILES
    C[C@@H](c(cc1)ccc1OC(F)(F)F)NC(CN1N=Nc(cccc2)c2C1=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wolf-Georg Forssmann, et al. Use of phosphodiesterase inhibitors in the treatment of prostatic diseases. US 8106061 B2
molnova catalog
related products
  • GPR81 agonist 1

    GPR81 agonist 1 is a potent and selective GPR81 agonist with high affinity for human and mouse GPR81, inhibiting lipolysis of differentiated 3T3-L1 adipocytes, improving insulin sensitivity and glycaemic control in mouse models of insulin resistance and diabetes, and can be used in the study of diabetes and obesity.

  • YUM70

    YUM70 is a potent and selective glucose-regulated protein 78 (GRP78) inhibitor(with an IC50 of 1.5 μM for inhibiting GRP78 ATPase activity of the full-length protein).?

  • BigLEN (mouse)

    GPR171 agonist. ProSAAS-derived neuropeptide. Regulates food intake in mice. Inhibits the release of glutamate onto parvocellular neurons of the paraventricular nucleus in a process dependent upon activation of postsynaptic G proteins.